Close



Aug 11, 2022 07:27AM
Jan 20, 2022 03:37AM
Oct 8, 2020 07:23AM
Jul 29, 2020 03:52AM
Oct 15, 2019 04:35AM
Oct 9, 2019 04:15AM
Jul 25, 2019 05:32AM Barclays Reiterates Equalweight Rating on GlaxoSmithKline (GSK)
Jul 15, 2019 03:04AM
May 2, 2019 01:25AM
Apr 10, 2019 03:21AM
Dec 4, 2018 12:02PM
Apr 10, 2018 05:41AM
Mar 27, 2018 01:12AM
Jan 16, 2018 11:58AM UPDATE: Barclays Upgrades GlaxoSmithKline (GSK) to Overweight
Nov 29, 2017 03:39AM
Aug 10, 2017 12:30PM
Mar 7, 2017 12:57PM
Mar 7, 2017 12:39PM
Oct 20, 2016 11:04AM
Jul 14, 2016 10:35AM
Oct 23, 2014 08:07AM Barclays Upgrades GlaxoSmithKline (GSK) to Overweight
Apr 22, 2014 10:21AM
Apr 2, 2014 09:33AM
Dec 17, 2013 10:46AM
Sep 16, 2013 07:47AM
May 13, 2013 09:31AM
Jan 29, 2013 10:57AM
Jan 29, 2013 09:10AM Barclays Upgrades GlaxoSmithKline (GSK) to Overweight
Jun 11, 2012 05:17PM
May 14, 2012 03:58PM
Oct 31, 2011 10:36AM
Oct 14, 2011 07:20AM
May 31, 2011 10:35AM
May 16, 2011 02:05PM
Mar 24, 2011 01:34PM Barclays Maintains an 'Overweight' on Quest Diagnostics (DGX); 2010 10-K Review
Mar 7, 2011 02:16PM
Feb 1, 2011 02:18PM
Jan 11, 2011 09:06AM
Jan 13, 2010 11:39AM
Nov 12, 2009 07:55AM
Oct 23, 2009 12:08PM
Oct 14, 2009 11:03AM Notable Analyst Rating Changes 10/14: CSC, GSK, SNY, ABX, CNO, HOG, TEL Upgrade; VLO, JBLU, AGCO Downgrade
Jun 11, 2009 09:55AM
Mar 17, 2009 10:54AM
Jan 26, 2009 10:02AM

96,605 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All